[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Zimmer Biomet Holdings Inc (ZBH)

Zimmer Biomet's stock price has declined over XX% in the last XX hours due to valuation concerns and analyst downgrades. Recent social media discussions highlight a 'short score' and hospital spending issues.

About Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc. is a medical device company specializing in musculoskeletal healthcare.
Zimmer Biomet Holdings Inc uses the ticker $ZBH for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Zimmer Biomet Holdings Inc (ZBH) market dominance near a 52-week low at XXXXXXX.
Zimmer Biomet Holdings Inc (ZBH) trading volume is up XXXXX% from the previous week.
Zimmer Biomet Holdings Inc (ZBH) social dominance is up 1275% from the previous week.
Zimmer Biomet Holdings Inc (ZBH) creators is up XXXXX% from the previous week.
Zimmer Biomet Holdings Inc (ZBH) engagements is up XXXXXX% from the previous week.
Zimmer Biomet Holdings Inc (ZBH) mentions is up XXXXX% from the previous week.
Zimmer Biomet Holdings Inc (ZBH) posts created is up XXXXXX% from the previous week.

Price: $XXXXX

Price 24-Hour Time-Series Raw Data
The stock price has declined over XX% in the last XX hours due to valuation concerns, analyst downgrades, and social media discussions about a 'short score' and hospital spending, overshadowing positive news like FDA breakthrough designation.

24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: XXXX%

1-Year High: $XXXXXX on 2025-03-31
1-Year Low: $XXXXX on 2025-11-05

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Zimmer Biomet Holdings Inc (ZBH) is currently AltRank #1,581 based on combined combined social and market metrics Daily Average: XXXXX
X Week: XXXXX +1,322
X Month: XXXXX +156
X Months: XXXXX +843
X Year: XXXXX +326
1-Year High: XXXXX on 2025-09-15
1-Year Low: XX on 2024-12-25

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-01-22
1-Year Low: X on 2025-09-08

Engagements: XX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
X Week: XXXXX +185%
X Month: XXXXXX -XX%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +11%
1-Year High: XXXXXXX on 2025-08-06
1-Year Low: XX on 2025-12-02

Engagements by network (24h): Reddit: X X: XX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +44%
X Month: XXX +11%
X Months: XXXXX +12%
X Year: XXXXX +60%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-12-06

Mentions by network (24h): Reddit: X X: XX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Zimmer Biomet Holdings Inc (ZBH) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX +40%
X Month: XXX +17%
X Months: XXXXX +103%
X Year: XXXXX +122%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-12-06

The most influential creators that mention Zimmer Biomet Holdings Inc in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@MarcJacksonLA	X	XXXXX	X	X

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% +13%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-07-20
1-Year Low: XX% on 2025-10-05

Most Supportive Themes:

FDA Breakthrough Designation: (30%) Zimmer Biomet received FDA breakthrough designation for its innovative joint infection prevention technology and Iodine Hip system.
Acquisition of Monogram Technologies: (20%) Zimmer Biomet has acquired Monogram Technologies, an AI-driven orthopedic robotics company, to enhance its offerings in orthopedic robotics and innovation.
Undervalued Stock Potential: (15%) Analysis suggests Zimmer Biomet shares are undervalued, with a DCF model estimating an intrinsic value significantly higher than the current market price, indicating a potential buying opportunity.

Most Critical Themes:

Stock Price Underperformance: (40%) Despite positive news, the stock price is down, suggesting that underperformance and valuation concerns are outweighing positive developments.
Mixed Sentiment: (30%) The overall sentiment surrounding Zimmer Biomet is mixed, with a current sentiment of XX% positive, indicating a portion of the social community has negative views.

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXXXX% +0.00765%
X Month: XXXXXXX% -XXXXXXX%
X Months: XXXXXXX% -XXXXXXX%
X Year: XXXXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-06-28
1-Year Low: XXXXXX% on 2025-12-06

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-04-01
1-Year Low: XXXXX% on 2025-11-05

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$2.90%
X Month: $XXXXXXXXXXXXXX +$1.10%
X Months: $XXXXXXXXXXXXXX -$0.45%
X Year: $XXXXXXXXXXXXXX -$14%
1-Year High: $XXXXXXXXXXXXXX on 2025-03-31
1-Year Low: $XXXXXXXXXXXXXX on 2025-11-05